Bridging the mental health treatment gap: Effects of a collaborative care intervention (matrix support) in the detection and treatment of mental disorders in a Brazilian city by Saraiva, Sonia et al.
1Saraiva S, et al. Fam Med Com Health 2020;8:e000263. doi:10.1136/fmch-2019-000263
Open access 
Bridging the mental health treatment 
gap: effects of a collaborative care 
intervention (matrix support) in the 
detection and treatment of mental 
disorders in a Brazilian city
Sonia Saraiva  ,1 Max Bachmann,2 Matheus Andrade,3 Alberto Liria4
To cite: Saraiva S, 
Bachmann M, Andrade M, 
et al.  Bridging the mental 
health treatment gap: effects 
of a collaborative care 
intervention (matrix support) in 
the detection and treatment of 
mental disorders in a Brazilian 
city. Fam Med Com Health 
2020;8:e000263. doi:10.1136/
fmch-2019-000263
1Leeds Institute of Health 
Sciences, University of Leeds, 
Leeds, UK
2Norwich Medical School, 
University of East Anglia, 
Norwich, UK
3Secretaria Municipal de Saúde 
(Municipal Health Department), 
Florianópolis, Brazil
4Departamento de 
Especialidades Médicas, 
Facultad de Medicina y Ciencias 
de la Salud, Universidad de 
Alcalá, Alcalá de Henares, Spain
Correspondence to
Dr Sonia Saraiva;  
 soniasaraiva@ hotmail. com
Original research
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published by 
BMJ.
ABSTRACT
Objective To analyse temporal trends in diagnosis and 
treatment of mental disorders in primary care following 
implementation of a collaborative care intervention (matrix 
support).
Design Dynamic cohort design with retrospective time- 
series analysis. Structured secondary data on medical 
visits to general practitioners of all study clinics were 
extracted from the municipal electronic records database. 
Annual changes in the odds of mental disorders diagnoses 
and antidepressants prescriptions were estimated by 
multiple logistic regression at visit and patient- year levels 
with diagnoses or prescriptions as outcomes. Annual 
changes during two distinct stages of the intervention 
(stage 1 when it was restricted to mental health (2005–
2009), and stage 2 when it was expanded to other areas 
(2010–2015)) were compared by adding year–period 
interaction terms to each model.
Setting 49 primary care clinics in the city of Florianópolis, 
Brazil.
Participants All adults attending primary care clinics of 
the study setting between 2005 and 2015.
Results 3 131 983 visits representing 322 100 patients 
were analysed. At visit level, the odds of mental disorder 
diagnosis increased by 13% per year during stage 1 (OR 
1.13, 95% CI 1.11 to 1.14, p<0.001) and decreased by 
5% thereafter (OR 0.95, 95% CI 0.94 to 0.95, p<0.001). 
The odds of incident mental disorder diagnoses decreased 
by 1% per year during stage 1 (OR 0.99, 95% CI 0.98 to 
1.00, p=0.012) and decreased by 7% per year during 
stage 2 (OR 0.93, 95% CI 0.92 to 0.93, p<0.001). The odds 
of antidepressant prescriptions in patients with a mental 
disorder diagnosis increased by 7% per year during stage 
1 (OR 1.07, 95% CI 1.05 to 1.20, p<0.001); this was driven 
by selective serotonin reuptake inhibitor prescriptions 
which increased 14% per year during stage 1 (OR 1.14, 
95% CI 1.12 to 1.18, p<0.001) and 9% during stage 2 (OR 
1.09, 95% CI 1.08 to 1.10, p<0.001). The odds of incident 
antidepressant prescriptions did not increase during stage 
1 (OR 1.00, 95% CI 0.97 to 1.02, p=0.665) and increased 
by 3% during stage 2 (OR 1.03, 95% CI 1.00 to 1.04, 
p<0.001). Changes per year were all significantly greater 
during stage 1 than stage 2 (p values for interaction terms 
<0.05), except for antidepressant prescriptions during 
visits (p=0.172).
Conclusion The matrix support intervention may increase 
diagnosis and treatment of mental disorders when 
inter- professional collaboration is adequately supported. 
Competing demands to the primary care teams can 
subsequently reduce these effects. Future studies should 
assess clinical outcomes and identify active components 
and factors associated with successful implementation.
INTRODUCTION
An estimated 35%–50% of people with 
mental disorders in high- income countries 
and 76%–85% in low- income and middle- 
income countries receive no treatment, 
what results in avoidable suffering, disability 
and economic loss.1 2 Anxiety and depres-
sive disorders have the highest estimated 
Key messages
Question
 ► What are the effects of the matrix support model of 
collaborative care in the detection and treatment of 
mental disorders by general practitioners in a devel-
oping primary care system?
Finding
 ► When implemented with on- site support to clini-
cal and administrative integration between mental 
health and primary care providers, the matrix sup-
port was associated with improved detection and 
treatment of mental disorders by general practi-
tioners (GPs).
Meaning
 ► Collaborative care models based on the matrix sup-
port components—advice and support to GPs and 
on- site specialist care provided by mental health 
professionals, coupled with joint case manage-
ment—might improve detection and treatment of 
mental disorders in primary care. Future studies 
with experimental designs and clinical outcomes are 
needed to establish the potential of this intervention 
in reducing the treatment gap in mental health.
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lifetime rates, of about 16% and 12%, respectively.2 Low- 
income and middle- income countries are hit harder due 
to a combination of low educational and socioeconomic 
attainment among the patients, poor work conditions of 
practitioners and inefficient use of resources, which are 
mostly invested in psychiatric hospitals despite the associ-
ation of these settings with poor health outcomes.1
Brazil is more affected than other low- income and 
middle- income countries, with mental disorders present 
in 29.6% of adult São Paulo residents—of whom two- thirds 
receive no treatment3—and over half of adults attending 
Petrópolis primary care (PC) practices.4 The combina-
tion of low recognition, diagnostic inaccuracy and low 
treatment offer in primary care practice may contribute 
to a treatment gap.5 Integrating mental health (MH) 
care into PC provision will improve the effectiveness of 
care by providing opportune access and early treatment 
while reducing associated stigma.1 This requires from 
primary care practitioners (PCPs) new knowledge and 
skills to identify, manage and refer mental disorders; and 
from MH providers, new roles of advising and support to 
PCPs.1 5 Several integration approaches have been tested; 
of these, collaborative care has the strongest evidence 
base.6–8
Collaborative care interventions aim to develop 
closer work relationships and improve continuity of 
care between PCPs and specialist providers, based on a 
multi- professional approach to care, structured manage-
ment plans and patient follow- up, and enhanced inter- 
professional communication.7–9 That is usually operated 
through advice and support from specialists to general 
practitioners (GPs) in the form of clinical discus-
sions, case management and specialist care to selected 
patients.7 10 11 Successful implementation relies on organ-
isational support to identify training needs and barriers, 
review professional roles and provide feedback about the 
integration.10 11
A number of high- quality trials and systematic reviews 
have shown that collaborative care is more effective than 
standard care for depression and anxiety,6 is cost- effective 
when compared with usual care,8 and has positive effects 
in terms of case detection, treatment offer, clinical 
outcomes and patient satisfaction.6–8 10 Most studies were 
conducted in experimental settings of the USA and the 
UK,7 and little is known about collaborative care in the PC 
practice settings of low- income and middle- income coun-
tries. Conducting studies in such settings may improve 
understanding of how successful research interventions 
are translated into real- world contexts.
Brazil, a middle- income country which has one of the 
world’s largest universal health systems, has increased 
access to healthcare in the last two decades through the 
Family Health Strategy (FHS), an approach to PC based 
on multi- professional teams with a doctor (general physi-
cian), nurse, nursing assistant and community health 
workers responsible for catchment areas of 3000–4000 
people.12 Within primary care, mental health profes-
sionals are integrated into the PC teams through the 
matrix support model, a locally adapted collaborative care 
model which aims to increase access to care and co- or-
dination.13 Matrix support was piloted in a few cities in 
the early 2000s as an MH intervention and, from 2008, it 
was expanded to other areas like rehabilitation and nutri-
tional care and scaled up as the federally funded NASF 
programme (original acronym for Family Health Support 
Teams), which had over 4000 teams implemented in 2016.
The matrix support intervention integrates key features 
of collaborative care like multi- professional care, enhanced 
communication and structured follow- up, to local innova-
tions like joint consultations between MH professionals 
and PCPs. Key similarities between the models are the 
centrality of enhanced communication and collaborative 
clinical work between providers.13 14 Table 1 summarises 
the components and activities of matrix support.
Previous studies suggested that the Brazilian matrix 
support model might have similar effects to other 
collaborative care models mentioned in the literature, 
for example, improving detection of mental disorders, 
co- ordination between MH and PC providers,15 and 
overall quality of PC teams.16 However, so far, there are 
no published evaluations of matrix support using routine 
services data. This study aimed to analyse the associa-
tion between implementation of matrix support in the 
Brazilian city of Florianópolis and the detection and 
Table 1 Key components and activities of the matrix support intervention
Components Activities
Advice and support from mental health to primary care 
professionals
Case discussion
Follow- up of treatment plans
On- site training and joint consultations
Specialist care provided by the mental health professionals Outpatient management of severe cases
Referral and liaison to other services
Joint case management and administrative activities Feedback on referrals and waiting lists
Agreement of local guidelines and protocols
Definition of professional roles in collaborative care
Identification of training and support needs
Source: adapted from Saraiva et al.14
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treatment of mental disorders by PCPs between 2005 and 
2015, as well as to compare two distinct stages of the inter-
vention, as a mental health- only programme and as part 
of the NASF programme, through statistical analysis of 
electronic medical record (EMR) data.
METHODS
Study setting
Florianópolis is a state capital in the south of Brazil of 
500 973 inhabitants in 2019.17 Primary care is based on the 
FHS model, and it was expanded from 48 FHS teams in 
2005, covering 42% of an estimated 394 285 inhabitants, 
to 150 teams in 2015 covering 100% of 469 690 inhabi-
tants. All residents are assigned to one of 49 municipal PC 
clinics in each of which work 1 to 6 FHS teams providing 
preventive care, nursing care, medical treatment, free 
medicines, preventive care and referrals. The city has 
long been recognised for the coverage and quality of 
primary care and mental health care18 19 and was awarded 
a Ministry of Health’s prize for its matrix support inter-
vention.20 Despite these achievements, the local health 
system faces constraints similar to other low- income and 
middle- income countries, like insufficient staff, poor 
physical structure and unequal access to healthcare.21
Implementation of the intervention
Matrix support was implemented in Florianópolis initially 
as an MH intervention (2005–2009) and further as part 
of the NASF programme (from 2010). These two periods 
correspond to two distinct stages of the matrix support 
intervention. In stage 1, the outpatient's referral system 
to MH professionals was replaced by regular meetings 
between PC and MH teams, in which both jointly agreed 
and monitored treatment plans and performed collabo-
rative activities like case discussions or joint visits. Those 
meetings were also used to on- site training through discus-
sion of diagnostic criteria for mental disorders, screening 
during routine consultations and feedback about the GP 
referrals to mental health professionals. Communication 
by phone or email between the meetings was encour-
aged, and selected patients were seen by the MH team 
or referred to MH services. A dedicated programme 
manager with MH background provided on- site support 
to the clinical and administrative integration.18 20
In stage 2, with funding from the NASF programme, 
the MH professionals were integrated into the broader 
NASF teams, where they needed to share the restricted 
time of the PC teams with other professionals like physio-
therapists and dietitians.22 The programme management 
was decentralised to middle managers who were already 
in charge of several other PC programmes, so less support 
was available for the integration between MH and PC 
professionals. Previous studies have stressed the impor-
tance of management support to successfully imple-
menting matrix support, through integrating distinct 
professionals’ agendas, guaranteeing regular meetings, 
and dealing with continuity gaps and communication 
problems.23 24 Therefore, less support for clinical integra-
tion was likely to negatively impact on the outcomes of 
the matrix support intervention.
Study design
This was a programme evaluation with a dynamic cohort 
design, that is, participants could enter and leave the 
cohort at any time, with a retrospective time- series analysis 
of outpatient attendances at health centres (PC clinics). 
The primary units of analysis were individual patients 
and their attendances (visits). Data were extracted from 
a consolidated EMR database, which registers all patient 
visits to the services of the city’s Municipal Health Secre-
tary. Structured data including age, gender, ICD-10 diag-
nostic code and drug prescriptions are recorded by all 
PC workers for each individual visit and then automati-
cally consolidated at clinic and system levels. Data were 
included while each PC clinic implemented the EMR 
system, which was expanded during the study period 
(from 13 clinics in 2005 to 49 in 2015).
Study population
Patients aged 18 years or over who had at least one 
visit to a GP in a PC clinic with the EMR system imple-
mented between 1 January 2005 and 31 December 2015 
were included. Visits to non- medical PC personnel, for 
example, nurses, were not included because although 
these professionals also participated in matrix support 
activities like case discussion and on- site training, they 
were not directly responsible for the diagnosis and treat-
ment of patients with mental disorders. Visits to non- PC 
services were not included because these services were 
not part of the intervention.
Outcomes
The following measures of detection and treatment of 
mental disorders by GPs were built on the available data, 
the intervention objectives and the mentioned previous 
research on collaborative care.
 ► Detection of mental disorders: the proportion of 
all visits in which any mental disorder diagnosis was 
recorded; the proportion of all patients attending 
during each calendar year in whom any mental 
disorder diagnosis was recorded during the same 
year; the proportion of all patients attending during 
each calendar year in whom any mental disorder 
diagnosis was recorded for the first time during the 
same year (‘incident diagnoses’). The ‘proportion of 
visits’ reflects changes in the workload of the GPs with 
mental disorders, while the ‘proportion of patients’ 
assesses whether more distinct patients with mental 
disorders were seen since the same patient might have 
several visits.
 ► Treatment of anxiety and depressive disorders: the 
proportion of all visits with a diagnosis of anxiety or 
depressive disorder recorded in which an antidepres-
sant was prescribed during the same visit; the propor-
tion of all patients who attended during a calendar 
P
rotected by copyright.
 on O
ctober 28, 2020 at U
niversity of E
ast A
nglia.
http://fm
ch.bm
j.com
/
F
am
 M
ed C
om
 H
ealth: first published as 10.1136/fm
ch-2019-000263 on 21 S
eptem
ber 2020. D
ow
nloaded from
 
4 Saraiva S, et al. Fam Med Com Health 2020;8:e000263. doi:10.1136/fmch-2019-000263
Open access 
year with an anxiety or depressive disorder diagnosed 
to whom an antidepressant was prescribed during the 
same year; the proportion of all patients who attended 
during a calendar year with an anxiety or depressive 
disorder diagnosed to whom an antidepressant was 
prescribed for the first time during the same year 
(‘incident treatments’). These outcomes are proxy 
indicators of access to treatment of these mental 
health conditions in primary care.
Anxiety and depressive disorders are generally viewed 
as the main remit of PC5 and are particularly frequent 
in Brazil.4 Both antidepressants and psychotherapy are 
effective treatments for most anxiety and depressive 
disorders, but only antidepressants (tricyclics and selec-
tive serotonin reuptake inhibitors—SSRIs) were regularly 
provided in the study clinics and had consistent records 
in the EMR database. SSRIs are associated with fewer side 
effects on depression treatment and are usually prefer-
able to tricyclics for anxiety disorders.25 Therefore, an 
analysis by antidepressant class was added to assess if any 
increases in treatments were driven by SSRIs, expressing 
adequacy of treatments. The analysis of prescriptions 
at visit and patient levels followed the same rationale 
explained previously for detection.
Each outcome was analysed for the whole period of 
study (2005–2015) and for each intervention stage sepa-
rately. Date limits were established on an annual basis 
(stage 1: 1 January 2005 to 31 December 2009; stage 2: 1 
January 2010 to 31 December 2015).
Data collection and management
Data on outcomes measures and baseline variables were 
extracted from the EMR database by one of the authors 
with authorisation of the Municipal Secretary of Health 
(local health authority) and securely stored at the Univer-
sity of East Anglia. Only secondary anonymised data were 
used. The authors had no access to patient identifiers.
Statistical analysis
Descriptive statistics are presented for baseline variables. 
Statistical analyses aimed to estimate annual changes in 
the odds of mental disorders being recorded during a GP 
visit or during a patient- year, and in the odds of antidepres-
sants being prescribed for visits of patients with anxiety or 
depressive disorders, or in a patient- year with anxiety or 
depressive disorder. Diagnosis of a mental disorder was 
defined as the recording of an ICD-10 code with an F 
prefix and of anxiety and depressive disorders as ICD-10 
codes F32-39 plus F40–48. Antidepressant prescrip-
tions were defined as any tricyclic or SSRI prescriptions 
recorded. For analyses of incident diagnoses or treat-
ments recorded for the first time during a year, patients 
were removed from the denominator population at risk if 
they had had the same diagnosis or treatment in previous 
years. The 95% CIs for proportions of patients or visits 
with each outcome were estimated with adjustment for 
clustering of outcomes within patients.
The effects of the intervention on outcomes were esti-
mated using segmented interrupted time series regres-
sion models.26 The regression model equations were:
Yt = β0 + β1T + β2Xt + β3TXt + βkK
where T represents the year, Xt is a dummy variable 
indicating stage 1 (coded 0) or stage 2 (coded 1), Yt 
represents the outcome at year t, β0 represents the base-
line level at year 0, β1 represents the change in outcome 
associated with an additional year during stage 1, β2 
represents the baseline difference in intercept for stage 2 
time trend, β3 is the change in time trend from stage 1 to 
stage 2 and βk is the vector of coefficients corresponding 
the other covariates K.26 TXt is thus an interaction term 
with a value of zero during stage 1 and a value of T during 
stage 2, and the time trend during stage 2 was obtained 
by multiplying β1 and β3. Modelling time as a continuous 
avoids the problem of time- stage collinearity and enables 
different trends to be estimated for each stage. All models 
included age and sex as covariates, used robust adjustment 
for intra- patient correlation of outcomes and included 
dummy variables for each clinic to account for intra- clinic 
correlation of outcomes. Modelling clinics as covariates is 
equivalent to multilevel modelling with randomly varying 
intercepts for clinics. Multilevel mixed regression models 
with both clinics and patients as random effects could 
not be computed because of the large sample with over 3 
million records. A 5% significance level was used. Statis-
tical analysis was done with Stata V.16.
RESULTS
Sample characteristics
There were 3 131 983 visits of adults (median age 46 
years) to GPs in the study clinics between 2005 and 
2015, of whom 207 314 (6.6%) had mental disorders 
recorded. Antidepressants were prescribed in 45.7% of 
the visits where anxiety or depressive disorder diagnosis 
was recorded. A total of 322 100 patients attended the 
visits, of whom 58 179 (18.0%) had a mental disorder ever 
recorded, and 46 378 (14.4%) had an anxiety or depres-
sive disorder ever recorded. Women comprised 68.7% 
of patients with mental disorders, and 74.7% of patients 
with anxiety or depressive disorders.
Detection of mental disorders
The proportions of visits and patients in which mental 
disorders diagnosis were recorded increased from 2005 
to 2010 and decreased after that (table 2, figure 1). 
Considering the entire period, from 2005 to 2015, there 
was no change each year in the odds of a mental disorder 
being recorded at any visit (OR 1.00 95% CI 1.00 to 1.00, 
p<0.441), after adjustment for gender and age.
In the comparison between intervention stages, the odds 
of visits having a mental disorder recorded during a visit 
increased by 13% per year during stage 1 and decreased 
by 5% per year during stage 2 (p for year–period inter-
action <0.001) (table 3). The odds of patients seen by 
a GP during a year having a mental disorder recorded 
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during the same year increased by 10% per year in stage 
1 and decreased by 3% per year in stage 2 (p for year–
stage interaction <0.001). The odds of incident mental 
disorder diagnoses decreased by 1% per year during stage 
1 (OR 0.99, 95% CI 0.98 to 1.00, p<0.012) and decreased 
by 7% per year during stage 2 (OR 0.93, 95% CI 0.92 to 
0.93, p<0.001).
Prescription of antidepressants
Among visits where a diagnosis of anxiety or depressive 
disorder was recorded, the probability of an antide-
pressant being prescribed increased between 2005 and 
2015 overall (table 4, figure 2). The odds of visits with 
an anxiety or depressive disorder recorded in which an 
antidepressant was prescribed increased by 19% per 
year during stage 1 and increased less rapidly, at 5% per 
year, during stage 2 (p for interaction=0.172) (table 3). 
In the analysis at patient- year level, the odds of any anti-
depressant being prescribed during a year increased by 
13% per year during stage 1 and by 7% during stage 2 (p 
for interaction <0.001). The odds of incident antidepres-
sant prescriptions did not increase during stage 1 (OR 
1.00, 95% CI 0.97 to 1.02, p=0.665) and increased by 3% 
during stage 2 (OR 1.03, 95% CI 1.00 to 1.04, p<0.001).
Splitting by antidepressant class, between 2005 and 2015, 
the probability of an SSRI being prescribed increased and 
the probability of tricyclics being prescribed decreased, 
in both visits and patient- year levels of analysis (table 4, 
figure 3). There was an 8% increase in SSRI prescrip-
tion and a 2% decrease per year in tricyclics prescription 
during visits over the whole period. There was a 10% 
increase per year in SSRI prescription and a 1% decrease 
per year in tricyclics prescription during patient- years. 
The prescription of tricyclics was independently more 
likely in older and female patients (adjusted OR 1.08 
(95% CI 1.06 to 1.09) per 10 years of age and 1.35 (95% 
CI 1.26 to 1.46), respectively, in visits; and 1.13 (95% CI 
1.11 to 1.15) per 10 years of age and 1.37 (95% CI 1.29 to 
1.46), respectively, during patient- years.
In the comparison between stages of the intervention, 
the odds of SSRI prescription during any visit increased 
by 14% per year during stage 1 and by 9% per year during 
stage 2 (p for year–stage interaction <0.001) (table 3). 
Tricyclic prescribing during visits increased by 3% per 
year during in stage 1 and decreased by 6% per year 
during stage 2 (p for interaction <0.001). In analysis at 
patient- year level, the odds of SSRI prescription during a 
year increased by 18% per year during stage 1 and by 10% 
per year during stage 2 (p for year–period interaction 
<0.001). Tricyclic prescription during a year increased by 
6% per year in stage 1 and decreased by 6.6% per year 
during stage 2 (p for year–period interaction <0.001).
DISCUSSION
This is the first study that reports mental health 
outcomes of the matrix support intervention based on 
routinely collected health services data. The results of T
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stage 1 (2005–2009) suggest that the matrix support 
between MH and PC professionals when implemented 
with on- site support for clinical and administrative 
integration was associated with improved detection of 
mental disorders and improved treatment of anxiety and 
depressive disorders. The same temporal trends were 
observed in the analysis at visits and patient- year levels, 
meaning that more distinct patients were diagnosed and 
treated for mental disorders in this period. These results 
are consistent with the matrix support overall goal of 
increasing access to care and with previous research on 
collaborative care.7 10 During stage 1, both diagnosis of 
mental disorders and SSRI prescribing increased, but 
during stage 2 both diagnosis and tricyclic prescribing 
decreased, while SSRI prescribing increased at a lower 
rate. The main changes in the intervention from stage 1 
to stage 2 which could explain such different results were 
the reduction of organisational support to services inte-
gration, and the increasing competing demands to the 
primary care teams with the expansion of matrix support 
to other areas beyond mental health. These factors 
should have reduced the intensity or quality of the clin-
ical collaboration between MH and PC professionals. 
This interpretation should be made with caution due 
to the number of possible intervening factors. Although 
the study design did not allow causal inference, its scale 
and pioneering, and the relevance of the matrix support 
for Brazil’s health system, make the findings of interest 
to policy- makers, managers and practitioners involved 
in integrating MH and PC, in Brazil and countries with 
similar health systems.
Sample features and recording issues
The predominance of middle- aged women was consistent 
with previous research conducted among PC attendees 
in Brazil, which show that being a woman was the socio-
demographic variable most associated with the chance 
of receiving MH care.27 This predominance might be 
explained by less dependence on others to access the 
services when compared with younger or older people, 
as well as a reduced perception of stigma associated with 
seeking MH care when compared with men.28
The finding of anxiety and depressive disorders as main 
diagnoses also followed the pattern usually observed 
in community surveys.3 The rates of mental disorders 
(18.0%) and anxiety and depressive disorders (14.4%) 
in our sample were lower than reported in other studies 
in PC populations; for example, one study in four major 
Brazilian cities found prevalence of anxiety and depres-
sion in adults attending PC clinics between 35%–43% and 
21%–31%, respectively.27 This difference in our findings 
may be due to methodological issues, rather than lack 
of recognition.29 Most services surveys use standardised 
diagnostic instruments, which are associated with higher 
diagnosis rates of mental disorders when compared with 
records of routine clinical practice.30 One survey in Brazil 
found that only 5.6% of PC attendees had a psychiatric 
diagnosis recorded, while 44.1% had an anxiety or depres-
sive disorder according to a standard instrument.31 Some 
reasons for this issue are high comorbidity, problems 
presenting in undifferentiated forms, and the preference 
of the GPs for recording symptoms or physical condi-
tions as reasons for visits instead of assigning a psychiatric 
Figure 1 Mental disorder diagnosis per visit and per patient, 2005–2015.
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label to patients, especially those with mild symptoms or 
social distress.29 32 This is especially relevant, considering 
that the EMR data obtained for this study only informed 
one ICD-10 code per visit. Ultimately, the analysis of GP 
records might say more about the provision of care than 
the prevalence or the need in the population.
Increase in detection and treatment of mental disorders
The prevalence of mental disorders is relatively stable in 
people presenting to PC,30 meaning that the increasing 
records observed in stage 1 reflect increased recogni-
tion of patients with mental disorders and, potentially, 
increased access to care. The increase in diagnoses 
during year or visit, together with no increase in incident 
diagnoses, suggests that patients in whom a diagnosis 
has already been made are having their mental disorder 
increasingly recognised by GPs at subsequent visits. 
Trends for antidepressants are similar; the small increase 
in incident treatments in stage 2 may represent patients 
previously recognised being now treated.
While higher recognition might occur at the expenses 
of oversensitivity and lack of specificity, and not neces-
sarily improve patient outcomes,33 a systematic review 
showed that non- psychiatric physicians indeed have 
low sensitivity (36.4%) and high specificity (83.7%) for 
diagnosing ‘true’ cases of depression, as defined by stan-
dardised diagnostic instruments.32 The increase in anti-
depressant prescription observed mostly in stage 1 also 
reflects improved access to care. The use of antidepres-
sant prescriptions alongside diagnostic codes to define 
depression was shown to improve case extraction from 
EMR data and be a better reflection of recognition by 
GPs,29 what may be due to GPs’ recording preferences 
discussed earlier.32 It remains an open debate to what 
extent GPs underdiagnose depression or instead avoid 
medicalising normal human distress.30 33
The increase in antidepressant prescription was driven 
by SSRIs, while tricyclics decreased, as observed in other 
collaborative care studies.6 Increased antidepressant use 
is a worldwide phenomenon associated with broader soci-
etal factors, including the availability of new drugs, broad-
ening of indications and advertising strategies.34 In major 
Brazilian cities, most people taking psychotropic drugs do 
not have mental disorders, while most people with mental 
disorders remain without treatment,35 a paradox also 
observed in other countries.28 In PC settings, overtreat-
ment with antidepressants is more related to prolonged 
use than to inadequate indication.36 GPs tend to continue 
prescriptions once they have started, for reasons which 
include patient pressure, time constraints and lack of 
treatment alternatives.37 The combination of societal 
trends and GP habits might explain why SSRI prescrip-
tions still increased in stage 2, despite reduced detection 
of mental disorders.
Distinct outcome patterns across stages of the intervention
The decrease of diagnoses and reduced treatment increase 
observed in stage 2 might be explained by differences in T
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organisational support and intensity of collaborative work 
after the introduction of the NASF programme. In stage 
1, the matrix support had a dedicated manager offering 
on- site support to clinical integration, mediation of 
administrative problems and feedback about outcomes, 
for example, waiting times. In stage 2, the institutional 
support was assigned to overwhelmed middle managers 
who were in charge of several programmes and only 
able to provide routine administrative supervision. 
Organisational support for integration including facilita-
tion of meetings, development of local guidelines, provi-
sion of training, supervision and feedback is associated 
with better staff engagement, change management and 
sustainability of the collaborative care.10 11 Conversely, 
weak local agreements and inconsistent guidance over 
time have been identified as barriers to implementa-
tion of matrix support in Brazil,38 as well as of collabo-
rative care in the USA.39 Only 22% of PC teams in Brazil 
Figure 2 Antidepressant prescriptions per visit and per patient, 2005–2015.
Figure 3 Proportion of each antidepressant class (tricyclics and selective serotonin reuptake inhibitors (SSRIs)) prescribed per 
visit and per year, 2005–2015.
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reported receiving any management support to imple-
ment matrix support.16 The broader scope of the matrix 
support teams in stage 2 (NASF teams) also implied more 
administrative complexity and competing demands to 
the PC teams, potentially reducing the opportunities for 
clinical collaboration between MH and PC teams. This is 
consistent with a previous study that evaluated the effects 
of a mental health training intervention in four Brazilian 
cities and suggested overload of PC teams with competing 
health problems as a possible explanation for reduced 
detection and treatment of mental disorders.40
Study limitations
This study had some limitations. First, the EMR registry 
provided no symptoms data; therefore, clinical outcomes 
were not assessed. However, antidepressant prescriptions 
have been previously used as a proxy of clinical outcomes 
in collaborative care for depression.6 7 Second, data on 
referrals to MH professionals, or concurrent care provided 
by them, was limited; it was not possible to assess conti-
nuity of care. Therefore, we could not compare our find-
ings with previous studies that suggest positive effects of 
matrix support interventions and the NASF programme 
in process outcomes like quality of referrals and commu-
nication between distinct providers.14 15 Third, the detec-
tion measures did not accurately express the incidence or 
prevalence of mental disorders, but rather estimates of 
care provision. However, previous research supports the 
use of a combination of diagnostic codes and antidepres-
sant prescriptions as an indicator of access to treatment.29 
Fourth, the treatment measures did not allow for any 
assessment of the quality of treatments in terms of dose, 
duration or patients’ adherence. In addition, there were 
no EMR data on the prescription of benzodiazepines due 
to local health legislation that requires such drugs to be 
prescribed only on paper. This prevented cross- checking 
of changes in prescription patterns; for example, whether 
the increased antidepressant prescription was accompa-
nied by reduction of benzodiazepines. Fifth, the degree 
of matrix support implementation possibly varied among 
the clinics and over time, and an analysis of such varia-
tion would add relevant information to the aggregated 
data; however, such assessment was not possible based on 
the EMR data and would request other research designs. 
Sixth, it is possible that some diagnoses and treatments 
were inaccurately recorded or missing, and that patients 
who left the cohort during the study may have been 
systematically different from those who continued to 
attend primary care, which could have biased results. 
In particular, changes in the accuracy and complete-
ness of recorded diagnoses and treatments would be 
most likely to have biased our findings if they changed 
over time. Lastly, this was an observational study, which 
allows very limited causal inference about the interven-
tion, for several reasons. Because EMRs were introduced 
at the same time as the matrix support intervention, we 
could not use these data to compare trends in diagnosis 
and prescribing before and after the intervention was 
introduced but could only compare two stages of the 
intervention having different intensities. It is possible 
that the changes observed during stage 1 might have 
happened even without the intervention because of 
other influences. Similarly, the changes in outcomes from 
stage 1 to stage 2 might also have been caused by other 
factors, that is, by unmeasured time- varying confounding 
variables. The only potential confounders that we were 
able to control for were age and sex, and it is possible 
that other unmeasured variables such as socioeconomic 
factors or comorbidities might have confounded our 
results, especially if these changed over time. Differences 
in the characteristics of the health centres included in the 
study might also have biased the results. However, a huge 
dataset of routine medical care was interrogated, which 
showed temporal trends consistent with the aims of the 
intervention, thereby providing a basis for effectiveness 
studies.
Implications for practice and research
The positive outcomes of stage 1 suggest that the matrix 
support intervention may increase access to treatments 
when implemented with adequate on- site support to 
clinical integration. In this study’s setting, the support to 
integration was provided by one full- time mental health 
worker for 50 PC practices, what is likely to be feasible 
in other primary care settings. The inconsistent results of 
stage 2 stress the need for a better understanding of how 
this programme is affected by variations in administra-
tive support and by competing demands to the primary 
care teams. These conditions are the rule in real- world 
primary care settings in which several programmes need 
to converge to provide patient- centred care and deal 
with multi- comorbidity. In particular, there is a need to 
better understand the specific contribution of supportive 
strategies, for example, on- site supervision; intervention 
components, for example, regular meetings; and other 
contextual factors, for example, competing programmes 
and lack of time of the PC teams to the matrix support 
outcomes. The use of routinely collected data to evaluate 
such experiences should be improved and encouraged, 
including the assessment of non- pharmacological compo-
nents, for example, psychological therapies, and system- 
level effects, for example, continuity of care. Future 
research should use experimental or quasi- experimental 
designs to assess clinical outcomes of the matrix support 
(eg, depression symptoms) across sites with distinct levels 
and modalities of matrix support, for example, mental 
health- only versus broader multi- professional teams; and 
across distinct groups of disorders like psychotic and 
common mental disorders.
CONCLUSION
This was the first study to show a positive association 
between implementation of the matrix support interven-
tion and improved detection and treatment of mental 
disorders in primary care, in particular anxiety and 
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depressive disorders. Our findings suggest that the effects 
of matrix support in mental health care may be favoured 
by on- site organisational support to the clinical integra-
tion between MH and PC workers. Conversely, competing 
demands to PCPs and reduced opportunities for clinical 
integration may reduce the effects of matrix support in 
mental health treatment provision.
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